Last updated on July 2019

A Study of Galcanezumab (LY2951742) in Adults With Treatment-Resistant Migraine


Brief description of study

The purpose of this study is to assess the safety and efficacy of galcanezumab in people with treatment-resistant episodic or chronic migraine.

Clinical Study Identifier: NCT03559257

Recruitment Status: Closed


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.